Your browser doesn't support javascript.
loading
Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy.
Darboe, Fatoumatta; Mbandi, Stanley Kimbung; Naidoo, Kogieleum; Yende-Zuma, Nonhlanhla; Lewis, Lara; Thompson, Ethan G; Duffy, Fergal J; Fisher, Michelle; Filander, Elizabeth; van Rooyen, Michele; Bilek, Nicole; Mabwe, Simbarashe; McKinnon, Lyle R; Chegou, Novel; Loxton, Andre; Walzl, Gerhard; Tromp, Gerard; Padayatchi, Nesri; Govender, Dhineshree; Hatherill, Mark; Karim, Salim Abdool; Zak, Daniel E; Penn-Nicholson, Adam; Scriba, Thomas J.
Afiliação
  • Darboe F; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology and Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Mbandi SK; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology and Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Naidoo K; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • Yende-Zuma N; MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • Lewis L; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • Thompson EG; MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • Duffy FJ; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • Fisher M; Center for Infectious Disease Research, Seattle, WA, United States.
  • Filander E; Center for Infectious Disease Research, Seattle, WA, United States.
  • van Rooyen M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology and Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Bilek N; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology and Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Mabwe S; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology and Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • McKinnon LR; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology and Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Chegou N; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology and Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Loxton A; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • Walzl G; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.
  • Tromp G; DST-NRF Centre of Excellence for Biomedical TB Research and South African Medical Research Council Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
  • Padayatchi N; DST-NRF Centre of Excellence for Biomedical TB Research and South African Medical Research Council Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
  • Govender D; DST-NRF Centre of Excellence for Biomedical TB Research and South African Medical Research Council Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
  • Hatherill M; DST-NRF Centre of Excellence for Biomedical TB Research and South African Medical Research Council Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
  • Karim SA; South African Tuberculosis Bioinformatics Initiative (SATBBI), Division of Molecular Biology and Human Genetics, Faculty of Medicine and Heath Sciences, Stellenbosch University, Tygerberg, South Africa.
  • Zak DE; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • Penn-Nicholson A; MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
  • Scriba TJ; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
Front Microbiol ; 10: 1441, 2019.
Article em En | MEDLINE | ID: mdl-31297103
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Microbiol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: África do Sul País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Microbiol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: África do Sul País de publicação: Suíça